Histone acetylation and CREB binding protein are required for neuronal resistance against ischemic injury

PLoS One. 2014 Apr 18;9(4):e95465. doi: 10.1371/journal.pone.0095465. eCollection 2014.

Abstract

Epigenetic transcriptional regulation by histone acetylation depends on the balance between histone acetyltransferase (HAT) and deacetylase activities (HDAC). Inhibition of HDAC activity provides neuroprotection, indicating that the outcome of cerebral ischemia depends crucially on the acetylation status of histones. In the present study, we characterized the changes in histone acetylation levels in ischemia models of focal cerebral ischemia and identified cAMP-response element binding protein (CREB)-binding protein (CBP) as a crucial factor in the susceptibility of neurons to ischemic stress. Both neuron-specific RNA interference and neurons derived from CBP heterozygous knockout mice showed increased damage after oxygen-glucose deprivation (OGD) in vitro. Furthermore, we demonstrated that ischemic preconditioning by a short (5 min) subthreshold occlusion of the middle cerebral artery (MCA), followed 24 h afterwards by a 30 min occlusion of the MCA, increased histone acetylation levels in vivo. Ischemic preconditioning enhanced CBP recruitment and histone acetylation at the promoter of the neuroprotective gene gelsolin leading to increased gelsolin expression in neurons. Inhibition of CBP's HAT activity attenuated neuronal ischemic preconditioning. Taken together, our findings suggest that the levels of CBP and histone acetylation determine stroke outcome and are crucially associated with the induction of an ischemia-resistant state in neurons.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Animals
  • Brain Ischemia / genetics*
  • Brain Ischemia / metabolism*
  • Brain Ischemia / pathology
  • CREB-Binding Protein / antagonists & inhibitors
  • CREB-Binding Protein / genetics*
  • CREB-Binding Protein / metabolism
  • Cerebral Cortex / cytology
  • Cerebral Cortex / metabolism
  • Cerebral Cortex / pathology
  • Curcumin / pharmacology
  • Disease Models, Animal
  • Gelsolin / genetics
  • Gene Expression
  • Gene Expression Regulation / drug effects
  • Gene Knockdown Techniques
  • Genetic Predisposition to Disease
  • Histones / metabolism*
  • Male
  • Mice
  • Mice, Knockout
  • Neurons / drug effects
  • Neurons / metabolism*
  • Promoter Regions, Genetic

Substances

  • Gelsolin
  • Histones
  • CREB-Binding Protein
  • Curcumin

Grants and funding

This work was supported by the German Research Foundation (Exc 257), the Federal Ministry of Education and Research (01 EO 08 01), the Helmholtz Association (SO-022NG) and has received funding from the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement no. 201024 (all given to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.